PND46 THE RISKS OF MULTIPLE GENERIC SUBSTITUTION OF ANTIEPILEPTIC DRUGS: THE CASE OFTOPIRAMATE
| Autor: | Lelorier, J, Duh, MS, Paradis, PE, Latremouille-Viau, D, Sheehy, O, Greenberg, P, Lee, SP, Rupnow, MF |
|---|---|
| Zdroj: | In Value in Health 2008 11(3):A151-A151 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect